ARTICLE | Clinical News
CERC-301: Phase II data
March 30, 2015 7:00 AM UTC
A double-blind, U.S. Phase II trial in 135 patients with MDD who recently experienced active suicidal ideation despite treatment with selective serotonin reuptake inhibitors (SSRI) or serotonin/norepi...